Bank Hapoalim BM’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-6,099
Closed -$1.25M 224
2017
Q3
$1.25M Buy
6,099
+844
+16% +$196K 0.28% 70
2017
Q2
$1.28M Sell
5,255
-531
-9% -$125K 0.3% 69
2017
Q1
$1.38M Sell
5,786
-2,961
-34% -$690K 0.32% 67
2016
Q4
$1.84M Buy
8,747
+3,458
+65% +$716K 0.49% 47
2016
Q3
$1.22M Buy
5,289
+1,017
+24% +$249K 0.29% 73
2016
Q2
$987K Buy
4,272
+1,999
+88% +$461K 0.23% 84
2016
Q1
$609K Buy
2,273
+1,180
+108% +$338K 0.14% 99
2015
Q4
$342K Sell
1,093
-51
-4% -$15.2K 0.08% 127
2015
Q3
$311K Sell
1,144
-208
-15% -$63.9K 0.07% 129
2015
Q2
$410K Buy
+1,352
New +$403K 0.08% 132

Other funds holding AGN

Bank Hapoalim BM's AGN Position: Q4 2017 in Review

Bank Hapoalim BM sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 6,099 shares — an estimated $1.25M sold.

Bank Hapoalim BM first reported a position in AGN in Q2 2015 and held it in 10 quarters. The position peaked at $1.84M in Q4 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Bank Hapoalim BM reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Bank Hapoalim BM sold 6,099 Allergan plc shares in Q4 2017, an estimated $1.25M.
  • Bank Hapoalim BM first reported a position in Allergan plc in Q2 2015 and held it in 10 quarters.
  • Bank Hapoalim BM's Allergan plc position peaked at $1.84M in Q4 2016.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Bank Hapoalim BM's 13F filing for Q4 2017, filed 5 Feb 2018.